~~<i id='EAABC11D9B'><strike id='EAABC11D9B'><tt id='EAABC11D9B'><pre id='EAABC11D9B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

explore

author：knowledge 2025-09-27 12:57:29 - browse：77234

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Trans patients at the end of life deserve respect and dignity

focus

leisure time

knowledge

entertainment

hotspot

leisure time

4:07WirefenceisseenoutsideoftheFultonCountyJailafteraGrandJurybroughtbackindictmentsagainstformerpre

WSS

Intellia plays down concerns on accidental germline transmission

Overprescribed: High cost isn't America's only drug problem

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Bird flu in dairy cattle: New measures to control spread to humans

Scientists uncover potential path to treating deadly childhood tumor

U.K. decision on ALS drug has neurologists, advocates up in arms

knowledge

explore

focus

Virginia high school admissions case could be legal follow

Bird flu reported in person exposed to presumably infected cattle

Novavax promises a turnaround & Lilly roils the obesity market

As obesity drug market grows, telehealth companies court payers

The cancer drug shortage isn’t new — and neither are the solutions

Study: Spinal cord stimulation helps patients with paralysis walk again

United colonoscopy coverage change 'may cost lives,' doctors say

Scientists uncover potential path to treating deadly childhood tumor

23andMe had bad news about my health. I wish a person had delivered it

How the drug

leisure time

FDA greenlights medical device to combat bladder issues

Multiple sclerosis has subtypes with different best treatments: study

Drug companies' payments and gifts affect physicians' prescribing

How to make over

National associations that represent hospice owe an apology

Covid silver lining: Unprecedented look at human immune system

knowledge

entertainment

hotspot

leisure time